• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
50,865.93 926.15
(1.85%)
Dow Jones
7,414.60 126.61
(1.74%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,316.43 61.62
(0.60%)
Forex
USD-INR
95.34 -0.07
(-0.08%)
EUR-INR
110.08 -0.10
(-0.09%)
GBP-INR
127.59 -0.01
(-0.01%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Biocon Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532523
INE376G01013
167.0598066
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BIOCON
283.54
67559.44
EPS(TTM)
Face Value()
Div & Yield %
1.47
5
0.12
 

Faze Three consolidated net profit rises 12.45% in the March 2026 quarter
May 23,2026
Net profit of Faze Three rose 12.45% to Rs 19.60 crore in the quarter ended March 2026 as against Rs 17.43 crore during the previous quarter ended March 2025. Sales rose 31.65% to Rs 277.18 crore in the quarter ended March 2026 as against Rs 210.55 crore during the previous quarter ended March 2025.

For the full year,net profit declined 17.44% to Rs 33.57 crore in the year ended March 2026 as against Rs 40.66 crore during the previous year ended March 2025. Sales rose 33.79% to Rs 923.07 crore in the year ended March 2026 as against Rs 689.94 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales277.18210.55 32 923.07689.94 34
OPM %12.2611.66 -8.9411.66 -
PBDT31.1028.15 10 72.7877.68 -6
PBT23.1421.29 9 42.0452.65 -20
NP19.6017.43 12 33.5740.66 -17